Medical Devices | Stent Lawsuits

Boston Scientific Taxus Stent News

New Taxus Stent Approved by EU for Additional Uses

RSS News Feeds
Medical Device Defects
Boston Scientific Taxus Stent
 All RSS Feeds

At a glance:

Boston Scientific's Taxus Liberte stent has received approval in Europe for the treatment of additional conditions. 
 
Originally, approval was granted for coronary artery disease; now the drug-coated stent may be used to treat in-stent restinosis (tissue overgrowth of a stent) and total arterial occlusion (total blockage).  
 
This new stent is easier for the surgeon to position, and has a lower complication rate, than Boston Scientific's older stent, Taxus Express2.

Boston Scientific stent gets added EU OK

BusinessWeek - 5/16/2006 4:01 PM

Medical device maker Boston Scientific Corp. said Tuesday it received additional European approval for its Taxus Liberte drug-coated stent.
 
The company said it received a CE mark for the Liberte to treat in-stent restenosis, or when tissue grows through the mesh of a stent to close up the blood vessel. It also received approval to treat total occlusions, or when the vessel becomes completely blocked. The new uses apply to patients with coronary artery disease including those who suffer from heart attacks
 
· Read The Full Boston Scientific Taxus Stent Article From BusinessWeek -->

· Read All Boston Scientific Taxus Stent News Stories -->

Comments On Boston Scientific Taxus Stent News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: